Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin in Chronic Intestinal Pseudo-obstruction
NCT04118699Phase 2Unknown
- Sponsor
- Yokohama City University
- Start
- Dec 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in chronic intestinal pseudo-obstruction (CIPO), sponsored by Yokohama City University. Status: unknown.
02
Drugs
rifaximin
03
Conditions
chronic intestinal pseudo-obstruction (CIPO)
Beyond the preview
Go deeper on NCT04118699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118699.